SCHEMBL29914341

SCHEMBL29914341

COCCC1(N)N=C(Nc2cc(-c3ccc(OC)cc3)no2)C=CN1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
RXFP1 Q9HBX9 2/20 0.41
CYP3A4 P08684 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2D6 P10635 1/20 0.38
SMN1; SMN2 Q16637 11/20 0.37
CYP1A2 P05177 1/20 0.37
RAB9A P51151 7/20 0.37
NPC1 O15118 6/20 0.37
MAPT P10636 5/20 0.36
ALDH1A1 P00352 4/20 0.36
LMNA P02545 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 2/20 0.36
POLB P06746 1/20 0.35
HTT P42858 1/20 0.35
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29914348 0.88 KMT2A (0.39) KMT2AMEN1RXFP1CYP3A4CYP2C9
SCHEMBL29914351 0.87 KMT2A (0.39) KMT2AMEN1RXFP1CYP3A4CYP2C9
SCHEMBL29914352 0.80 CYP3A4 (0.40) KMT2AMEN1RXFP1CYP3A4CYP2C9
SCHEMBL4464611 0.71 SMN1; SMN2 (0.47) KMT2ACYP3A4CYP2C9SMN1; SMN2CYP1A2
SCHEMBL22504981 0.68 KMT2A (0.59) KMT2AMEN1RXFP1CYP3A4CYP2C9
SCHEMBL23365250 0.65 CYP3A4 (0.43) KMT2AMEN1RXFP1CYP3A4CYP2C9
SCHEMBL24590357 0.64 MEN1 (0.55) KMT2AMEN1RXFP1CYP3A4CYP2C9
SCHEMBL23378500 0.64 CYP3A4 (0.57) KMT2AMEN1RXFP1CYP3A4CYP2C9
SCHEMBL24590147 0.63 KMT2A (0.54) KMT2AMEN1RXFP1CYP3A4CYP2C9
SCHEMBL24590317 0.62 MEN1 (0.53) KMT2AMEN1RXFP1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115279754-A Isoxazole derivatives targeting TACC3 as anticancer agents A2A制药有限公司 2022-11-01 CN claimed
CN-115279754-A Isoxazole derivatives targeting TACC3 as anticancer agents A2A制药有限公司 2022-11-01 CN disclosed